Sparrow Pharmaceuticals
Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.
Business Model:
Revenue: $0
Employees: 1-10
Industries / Tags:
Detailed Sparrow Pharmaceuticals Information
Geographic Data
Address: 920 SW 6th Avenue
City: Portland
State: OR
Zip: 97204
Country: US
Financial Info
Stage:
series a
Raised Last:
$50M
Raised Total:$50M
Social
Metrics
9,476,177Website Global Rank
147Website Monthly Traffic
Twitter Followers
Description
Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess. It was founded to spare patients the ravages of steroids. Leveraging underappreciated scientific insights into corticosteroid biology, the company is working to provide better treatment options for serious disorders of hypercortisolism and to revolutionize the treatment of autoimmune and inflammatory conditions. Its lead product, SPI-62, is an oral, small molecule, a novel treatment designed to target the source of active intracellular corticosteroids in key tissues. The company was founded in 2013 by David A. Katz and is based in Portland, Oregon, United States.
Contact Phone:
+16174650328
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2018 | Debt | $270k | 1/2021 | Funding Round | $1.1M | 5/2021 | Series A | 3 | $50M |
OrbiMed RiverVest U.S. Venture Partners OrbiMed RiverVest U.S. Venture Partners |
1/2021 | Venture Round | $1.1M |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
